1. Home
  2. ZLAB vs MGNI Comparison

ZLAB vs MGNI Comparison

Compare ZLAB & MGNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • MGNI
  • Stock Information
  • Founded
  • ZLAB 2013
  • MGNI 2007
  • Country
  • ZLAB China
  • MGNI United States
  • Employees
  • ZLAB N/A
  • MGNI N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • MGNI Computer Software: Programming Data Processing
  • Sector
  • ZLAB Health Care
  • MGNI Technology
  • Exchange
  • ZLAB Nasdaq
  • MGNI Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • MGNI 2.4B
  • IPO Year
  • ZLAB 2017
  • MGNI N/A
  • Fundamental
  • Price
  • ZLAB $32.54
  • MGNI $22.69
  • Analyst Decision
  • ZLAB Buy
  • MGNI Strong Buy
  • Analyst Count
  • ZLAB 5
  • MGNI 13
  • Target Price
  • ZLAB $54.28
  • MGNI $21.54
  • AVG Volume (30 Days)
  • ZLAB 781.8K
  • MGNI 3.3M
  • Earning Date
  • ZLAB 08-05-2025
  • MGNI 08-06-2025
  • Dividend Yield
  • ZLAB N/A
  • MGNI N/A
  • EPS Growth
  • ZLAB N/A
  • MGNI N/A
  • EPS
  • ZLAB N/A
  • MGNI 0.21
  • Revenue
  • ZLAB $418,326,000.00
  • MGNI $674,622,000.00
  • Revenue This Year
  • ZLAB $44.07
  • MGNI $0.32
  • Revenue Next Year
  • ZLAB $49.13
  • MGNI $11.02
  • P/E Ratio
  • ZLAB N/A
  • MGNI $105.79
  • Revenue Growth
  • ZLAB 43.72
  • MGNI 5.59
  • 52 Week Low
  • ZLAB $16.01
  • MGNI $8.22
  • 52 Week High
  • ZLAB $44.34
  • MGNI $25.27
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 40.19
  • MGNI 64.93
  • Support Level
  • ZLAB $34.26
  • MGNI $23.25
  • Resistance Level
  • ZLAB $35.72
  • MGNI $25.27
  • Average True Range (ATR)
  • ZLAB 1.12
  • MGNI 0.99
  • MACD
  • ZLAB -0.54
  • MGNI -0.05
  • Stochastic Oscillator
  • ZLAB 3.83
  • MGNI 64.99

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About MGNI Magnite Inc.

Magnite Inc is one of the supply-side platform providers, or SSP, in online advertising. The firm generate its revenue from the programmatic sale of CTV ad inventory, from mobile online sites and apps, and the remaining from websites accessed via computer.

Share on Social Networks: